Article Details

Sage Therapeutics and Biogen Announce the Phase 3 SKYLARK Study of Zuranolone in ...

Retrieved on: 2022-06-02 14:30:16

Tags for this article:

Click the tags to see associated articles and topics

Sage Therapeutics and Biogen Announce the Phase 3 SKYLARK Study of Zuranolone in .... View article details on hiswai:

Excerpt

Postpartum depression (PPD) is one of the most common medical complications during and after pregnancy impacting approximately 1 in 8 women ...

Article found on: news.unchealthcare.org

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up